Free Trial

Avidity Biosciences (RNA) Earnings Date, Estimates & Call Transcripts

Avidity Biosciences logo
$42.71 -0.94 (-2.15%)
(As of 11/21/2024 ET)

Avidity Biosciences Latest Earnings Summary

Upcoming
Earnings Date
Feb. 26Estimated
Actual EPS
(Nov. 7)
-$0.65 Beat By $0.14
Consensus EPS
(Nov. 7)
-$0.79

Avidity Biosciences announced Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.65, which topped the consensus estimate of -$0.79 by $0.14. Quarterly revenue was reported to be $2.34 million, below analysts' expectations of $7.09 million. With a trailing EPS of -$2.88, Avidity Biosciences' earnings are expected to decrease next year, from ($2.84) to ($3.17) per share.

RNA Upcoming Earnings

Avidity Biosciences' next earnings date is estimated for Wednesday, February 26, 2025, based off prior year's reporting schedules.

Get Avidity Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avidity Biosciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

RNA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RNA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Avidity Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.78-$0.78-$0.78
Q2 20241-$0.80-$0.80-$0.80
Q3 20241-$0.83-$0.83-$0.83
Q4 20241-$0.87-$0.87-$0.87
FY 20244-$3.28-$3.28-$3.28
Q1 20251-$0.88-$0.88-$0.88
Q2 20251-$0.90-$0.90-$0.90
Q3 20251-$0.92-$0.92-$0.92
Q4 20251-$0.93-$0.93-$0.93
FY 20254($3.63)($3.63)($3.63)

Avidity Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/26/2025
(Estimated)
------- 
11/7/2024--$0.79-$0.65+$0.14-$0.65$7.09M$2.34M
8/9/2024--$0.76-$0.65+$0.11-$0.65$7.09M$2.05M  
5/15/2024--$0.81-$0.79+$0.02-$0.79$7.09M$3.54M  
2/28/2024Q4 2023-$0.54-$0.79 -$0.25-$0.79$32.08M$2.19M  
11/8/2023Q3 2023-$0.76-$0.71+$0.05-$0.71$2.09M$2.82M  
8/8/2023Q2 2023-$0.84-$0.66+$0.18-$0.66$2.09M$2.32M  
5/9/2023Q1 2023-$0.90-$0.74+$0.16-$0.74$2.08M$2.23M  
2/28/2023Q4 2022-$0.84-$0.88 -$0.04-$0.88$2.39M$2.77M  

Avidity Biosciences Earnings - Frequently Asked Questions

Avidity Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates. Learn more on RNA's earnings history.

In the previous quarter, Avidity Biosciences (NASDAQ:RNA) reported ($0.65) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.79) by $0.14. Learn more on analysts' earnings estimate vs. RNA's actual earnings.

Avidity Biosciences (NASDAQ:RNA) has a recorded annual revenue of $9.56 million.

Avidity Biosciences (NASDAQ:RNA) has a recorded net income of -$212.22 million. RNA has generated -$2.88 earnings per share over the last four quarters.

Avidity Biosciences's earnings are expected to decrease from ($2.84) per share to ($3.17) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:RNA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners